Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Temsirolimus Resistance”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Testing effectiveness (Phase 2)Study completedNCT01798446
What this trial is testing

A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus

Who this might be right for
Renal Cell CarcinomaNonclear CellTemsirolimus Resistance
Seoul National University Hospital 41
Testing effectiveness (Phase 2)Study completedNCT00827684
What this trial is testing

Temsirolimus and Irinotecan for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations

Who this might be right for
Metastatic Colorectal Cancer
Vejle Hospital 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05835999
What this trial is testing

Everolimus Aging Study

Who this might be right for
AgingInsulin Resistance
University of Wisconsin, Madison 106
Testing effectiveness (Phase 2)Ended earlyNCT00887640
What this trial is testing

Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 11
Early research (Phase 1)Study completedNCT00703625
What this trial is testing

Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies

Who this might be right for
Resistant Solid Malignancies
Washington University School of Medicine 26
Testing effectiveness (Phase 2)Looking for participantsNCT05144698
What this trial is testing

RAPA-201 Therapy of Solid Tumors

Who this might be right for
Solid TumorSmall Cell and Non-small Cell Lung CancerHead and Neck Cancer+6 more
Rapa Therapeutics LLC 37
Testing effectiveness (Phase 2)Study completedNCT01206036
What this trial is testing

CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS)

Who this might be right for
Prostatic Neoplasms
Central European Society for Anticancer Drug Research 19
Early research (Phase 1)Study completedNCT00770263
What this trial is testing

Erlotinib and Temsirolimus for Solid Tumors

Who this might be right for
Solid Tumors
Washington University School of Medicine 46
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Early research (Phase 1)Study completedNCT01054313
What this trial is testing

Docetaxel and Sirolimus in Patients With Advanced Malignancies

Who this might be right for
Advanced Cancer
M.D. Anderson Cancer Center 103
Early research (Phase 1)Study completedNCT00703170
What this trial is testing

Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies

Who this might be right for
Resistant Solid Malignancies
Washington University School of Medicine 28
Not applicableEnded earlyNCT02306135
What this trial is testing

Identifying Mechanisms of Resistance to mTOR Inhibitors in Cancer

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 2
Early research (Phase 1)Ended earlyNCT01174199
What this trial is testing

Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateHormone-resistant Prostate Cancer+2 more
Roswell Park Cancer Institute 13
Not applicableWithdrawnNCT07329088
What this trial is testing

Isoleucine Addition Treatment Effects in a Controlled Diet Study

Who this might be right for
Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)Metabolic Syndrome (MetS)Obesity & Overweight
Jean L. Fry
Testing effectiveness (Phase 2)Study completedNCT02407054
What this trial is testing

Enzalutamide and LY3023414 in Men With Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Eli Lilly and Company 142
Testing effectiveness (Phase 2)Study completedNCT01026623
What this trial is testing

Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Study completedNCT00919035
What this trial is testing

Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 21
Not applicableStudy completedNCT02444390
What this trial is testing

Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor

Who this might be right for
Metastatic Breast Cancer
UNICANCER 150
Not applicableLooking for participantsNCT05233722
What this trial is testing

MTOR as Mediator of Insulin Sensitivity Study

Who this might be right for
Insulin Sensitivity
University of Copenhagen 10
Early research (Phase 1)Study completedNCT03646240
What this trial is testing

ABI-009 (Nab-rapamycin) for Surgically-Refractory Epilepsy (RaSuRE)

Who this might be right for
Epilepsy Intractable
Seattle Children's Hospital 14
Load More Results